Ghent-based biotech company Biotalys will soon be listed on the Brussels stock exchange. With the listing, the company, a supplier of biological control of plant fungi and insects, hopes to raise additional capital. How much exactly is not yet known.
De Tijd knows that more will be revealed next week. The prospectus must then be approved by the stock market watchdog FSMA.
Since the start of the company in 2013, already 63 million euros was raised.
Source: De Tijd